Table.
Therapy at each stage of chronic obstructive pulmonary disease, by GOLD stage1
| 1 (mild) | 2 (moderate) | 3 (severe) | 4 (very severe) | |
|---|---|---|---|---|
| FEV1:FVC | <0·70 | <0·70 | <0·70 | <0·70 |
| FEV1 | ≥80% of predicted | 50–80% of predicted | 30–50% of predicted | <30% of predicted or <50% of predicted plus chronic respiratory failure |
| Treatment | Influenza vaccination and short-acting bronchodilator* when needed | Influenza vaccination, short-acting and ≥1 long-acting bronchodilator* when needed; consider respiratory rehabilitation | Influenza vaccination and short-acting and ≥1 long-acting bronchodilator* when needed, inhaled glucocorticosteroid if repeated exacerbations; consider respiratory rehabilitation | Influenza vaccination and short-acting and ≥1 long-acting bronchodilator* when needed, inhaled glucocorticosteroid if repeated exacerbations, long-term oxygen if chronic respiratory failure occurs; consider respiratory rehabilitation and surgery |
GOLD=Global Initiative on Obstructive Lung Disease.
β2 agonists or anticholinergics.